Covid-19的心电图现象:莫斯科IT中心电视心电图研究的分析
- 作者: Taskina V.Y.1, Demkina A.E.1, Gazashvili T.M.2, Shkoda A.S.2, Vladzymyrskyy A.V.3,4, Morozov S.P.1
-
隶属关系:
- Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department
- L.A. Vorokhobov City Clinical Hospital No. 67 of the Moscow Healthcare Department
- Moscow Center for Diagnostics and Telemedicine
- The First Sechenov Moscow State Medical University (Sechenov University)
- 期: 卷 2, 编号 3 (2021)
- 页面: 235-248
- 栏目: 原创性科研成果
- URL: https://journals.rcsi.science/DD/article/view/71885
- DOI: https://doi.org/10.17816/DD71885
- ID: 71885
如何引用文章
详细
论证通过新的冠状病毒感染(Covid-19),随着病理过程中呼吸器官的主要损伤,涉及一种心血管系统。然而,在可用文献中,心电图(ECG)现象的分析估计是基于对小样本的研究结果和单一临床病例的描述,这决定了开展更多大规模研究以澄清性质和患病率的相关性ECG改变冠状病毒感染的人。
目标是构建Covid-19患者ECG的变化,代表莫斯科居民的非选择性人口。
材料与方法心电图研究的回顾性分析,42,799名患者在10.03.2020至10.03.2021期间验证了Covid-19验证诊断。 所有包括在研究人员中的所有人都在莫斯科的临床医院通过住院治疗,连接到ECG IT中心。 12根标准导联上进行ECG登记, 然后,通过互联网连接,将信息传输到ECG IT中心服务器,以形成相关结论。
结果。54%的患者中检测到ECG变化。最常见的心律失常是心室外收缩和心房颤动,分别占12.6%和12.0%。12.5%的患者表现出右心室过载的迹象,其中1.13%的患者表现出肺动脉血栓栓塞的心电图模式。 心电图梗死样改变发生在4.5%的受试者中,包括3例Brugada型。 ST-T发生变化的发生频率为所有研究的数量的2.2%。 带有细长QT和QTC间隔的ECG在540(1.26%)患者中注册。 报告了不同程度的心室颤动,弗雷德里克综合征和AB阻滞的单位病例.
结论。基于分析,获得了Covid-19患者心电图现象的发生频率的思路。 确认心房颤动的高发病率 - 血栓栓塞并发症的危险因素。 与此同时,建立了右侧心脏部门过载的ECG模式的显着普遍性,其中一些与光动脉的血栓栓塞相关。 其他观察到的ECG变化的特征在于显着较差的患病率,然而,这不会降低其临床意义。 未来的收集材料可以是冠状病毒感染的患者管理策略的优化。
作者简介
Varvara Y. Taskina
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department
Email: varvara.taskina@gmail.com
ORCID iD: 0000-0003-4452-7667
SPIN 代码: 6314-8190
MD, Cand. Sci. (Med.), Researcher, Telemedicine Research Projects Sector
俄罗斯联邦, 24 bld.1, Petrovka street, Moscow, 127051Alexandra E. Demkina
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department
Email: a.demkina@npcmr.ru
ORCID iD: 0000-0001-8004-9725
SPIN 代码: 4657-5501
MD, Cand. Sci. (Med.), Head of the Telemedicine Research Projects Sector
俄罗斯联邦, 24 bld.1, Petrovka street, Moscow, 127051Tamara M. Gazashvili
L.A. Vorokhobov City Clinical Hospital No. 67 of the Moscow Healthcare Department
Email: tamaradoc24@gmail.com
ORCID iD: 0000-0002-5875-9699
SPIN 代码: 4208-2303
MD, Head of the Center for Diagnostic Investigations
俄罗斯联邦, 2/44, Salyama Adilya street, 123423 MoscowAndrey S. Shkoda
L.A. Vorokhobov City Clinical Hospital No. 67 of the Moscow Healthcare Department
Email: a.shkoda@67gkb.ru
ORCID iD: 0000-0002-9783-1796
SPIN 代码: 4520-2141
MD, Dr. Sci. (Med.), Professor, Chief Physician
俄罗斯联邦, 2/44, Salyama Adilya street, 123423 MoscowAnton V. Vladzymyrskyy
Moscow Center for Diagnostics and Telemedicine; The First Sechenov Moscow State Medical University (Sechenov University)
编辑信件的主要联系方式.
Email: a.vladzimirsky@npcmr.ru
ORCID iD: 0000-0002-2990-7736
SPIN 代码: 3602-7120
MD, Dr. Sci. (Med.), Deputy Director for Science; professor of the Department of Information and Internet Technologies
俄罗斯联邦, 24 bld.1, Petrovka street,127051 Moscow; 8 bld.2, Trubetskaya street, 119991 MoscowSergey P. Morozov
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Healthcare Department
Email: morozov@npcmr.ru
ORCID iD: 0000-0001-6545-6170
SPIN 代码: 8542-1720
MD, Dr. Sci. (Med.), Professor
俄罗斯联邦, 24 bld.1, Petrovka street, Moscow, 127051参考
- Wu Z, McGoogan JM. Characteristics of and important lessons from the Coronavirus Disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323(13):1239–1242. doi: 10.1001/jama.2020.2648
- Shi S, Qin M, Shen B, et al. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in wuhan, China. JAMA Cardiol. 2020;5(7):802–810. doi: 10.1001/jamacardio.2020.0950
- Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system: a review. JAMA Cardiol. 2020;5(7):831–840. doi: 10.1001/jamacardio.2020.1286
- Vidovich MI. Transient Brugada-like electrocardiographic pattern in a patient with COVID-19. JACC Case Rep. 2020;2(9):1245–1249. doi: 10.1016/j.jaccas.2020.04.007
- Gérard A, Romani S, Fresse A, et al. "Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers. Therapie. 2020;75(4):371–379. doi: 10.1016/j.therap.2020.05.002
- Mai F, Del Pinto R, Ferri C. COVID-19 and cardiovascular diseases. J Cardiol. 2020;76(5):453–458. doi: 10.1016/j.jjcc.2020.07.013
- Ryabykina GV. ECG changes in COVID-19. Kardiologiia. 2020; 60(8):16–22. (In Russ). doi: 10.18087/cardio.2020.8.n1192
- Poteshkina NG, Lysenko MA, Kovalevskaya EA, et al. Cardiac damage in patients with COVID-19 coronavirus infection. Arterial Hypertension. 2020;26(3):277–287. (In Russ). doi: 10.18705/1607-419X-2020-26-3-277-287
- Lanza GA, De Vita A, Ravenna SE, et al. Electrocardiographic findings at presentation and clinical outcome in patients with SARS-CoV-2 infection. Europace. 2021;23(1):123–129. doi: 10.1093/europace/euaa245
- Morozov SP, Vladzimirskyy AV, Demkina AE, et al. Centralization of descriptions of electrocardiographic studies in primary health care: guidelines. The series "Best practices of radiation and instrumental diagnostics". Issue 62. Moscow: Scientific and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Department of Healthcare of the City of Moscow; 2020. 24 p. (In Russ).
- Morozov SP, Vladzimirskyy AV, Simenyura SS, et al. Digitalization of primary functional diagnostics data (example of electrocardiographic studies). Creative Cardiology. 2020;14(1):16–23. doi: 10.24022/1997-3187-2020-14-1-16-23
- Li Y, Liu T, Tse G, et al. Electrocardiograhic characteristics in patients with coronavirus infection: A single-center observational study. Ann Noninvasive Electrocardiol. 2020;25:e12805. doi: 10.1111/anec.12805
- Bertini M, Ferrari R, Guardigli G, et al. Electrocardiographic features of 431 consecutive, critically ill COVID-19 patients: An insight into the mechanisms of cardiac involvement. Europace. 2020;22(12):1848–1854. doi: 10.1093/europace/euaa258
- Angeli F, Spanevello A, De Ponti R, et al. Electrocardiographic features of patients with COVID-19 pneumonia. Eur J Intern Med. 2020;78:101–106. doi: 10.1016/j.ejim.2020.06.015
- Demkina AE, Morozov SP, Vladzymyrskyy AV, et al. Risk factors for outcomes of COVID-19 patients: an observational study of 795572 patients in Russia. medRxiv. 2020;11.02.20224253. doi: 10.1101/2020.11.02.20224253
- Atrial fibrillation and flutter. Clinical guidelines (approved by the Ministry of Health of the Russian Federation). 2020. Available from: https://scardio.ru/content/Guidelines/2020/Clinic_rekom_FP_TP.pdf. Accessed: 21.05.2021.
- Hu YF, Cheng WH, Hung Y, et al. Management of atrial fibrillation in COVID-19 pandemic. Circ J. 2020;84(10):1679–1685. doi: 10.1253/circj.CJ-20-0566
- Wang Y, Chen L, Wang J, et al. Electrocardiogram analysis of patients with different types of COVID-19. Ann Noninvasive Electrocardiol. 2020;25(6):e12806. doi: 10.1111/anec.12806
- Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in wuhan, China [published correction appears in JAMA. 2021 Mar 16;325(11):1113]. JAMA. 2020;323(11):1061–1069. doi: 10.1001/jama.2020.1585
- Shlyakhto EV, Parmon EV, Berngardt ER, Zhabina ES. Features of electrocardiographic changes in non-coronarogenic syndromes in patients with COVID-19. Russian Journal of Cardiology. 2020; 25(7):4019. (In Russ). doi: 10.15829/1560-4071-2020-4019.
补充文件
![](/img/style/loading.gif)